{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:17:07Z","timestamp":1772471827937,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":149,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005721","name":"Universit\u00e4t Bielefeld","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Spine"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.bas.2025.104292","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:44:51Z","timestamp":1748832291000},"page":"104292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inadvertent intrathecal application of vindesine and its neurological outcome: case report and systematic review of the literature"],"prefix":"10.1016","volume":"5","author":[{"given":"A.","family":"Babaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/02724936.1992.11747596","article-title":"Fatal myeloencephalopathy due to intrathecal vincristine administration","volume":"12","author":"Al Fawaz","year":"1992","journal-title":"Ann. Trop. Paediatr."},{"issue":"2\u20133","key":"10.1016\/j.bas.2025.104292_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s003810050338","article-title":"Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection","volume":"15","author":"Al Ferayan","year":"1999","journal-title":"Childs Nerv. Syst."},{"issue":"5","key":"10.1016\/j.bas.2025.104292_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1081\/CLT-120014647","article-title":"Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion","volume":"40","author":"Alcaraz","year":"2002","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00254046","article-title":"Vindesine effect in myeloid leukemia","volume":"8","author":"Baccarani","year":"1982","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00314787","article-title":"Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects","volume":"238","author":"Bain","year":"1991","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib6","first-page":"416","article-title":"Pyridoxine-dependent and pyridoxine-responsive seizures","volume":"43","author":"Baxter","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"issue":"5","key":"10.1016\/j.bas.2025.104292_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00002826-199110000-00011","article-title":"Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses","volume":"14","author":"Bleck","year":"1991","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib8","first-page":"527","article-title":"Metabolism and pharmacokinetics of oxazaphosphorines","volume":"42","author":"Boddy","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bas.2025.104292_bib9","doi-asserted-by":"crossref","unstructured":"Brade, W.P.,Critical review of pharmacology, toxicology, pharmacokinetics of vincristine, vindesine, vinblastine. International Vinca Alkaloid Symposium - Vindesine: Proceedings W. Brade, G.A. Nagel, S. Seeber. Volume 6. Chapters 95\u2013123; 1981.","DOI":"10.1159\/000428623"},{"issue":"5","key":"10.1016\/j.bas.2025.104292_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/j.1875-9114.1983.tb03269.x","article-title":"Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid","volume":"3","author":"Cersosimo","year":"1983","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.bas.2025.104292_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000441380","article-title":"Two fatal cases of accidental intrathecal vincristine administration: learning from death events","volume":"61","author":"Chotsampancharoen","year":"2016","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/PAF.0b013e3181c21c10","article-title":"Accidental intrathecal administration of vincristine","volume":"31","author":"D'Addario","year":"2010","journal-title":"Am. J. Forensic Med. Pathol"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0379-0738(01)00394-2","article-title":"Fatal myeloencephalopathy due to accidental intrathecal vincristine administration: a report of two cases","volume":"122","author":"Dettmeyer","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.bas.2025.104292_bib14","series-title":"Cancer Chemotherapy Handbook","author":"Dorr","year":"1980"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568011023354452","article-title":"Novel aspects of natural and modified vinca alkaloids","volume":"2","author":"Duflos","year":"2002","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568011023354452","article-title":"Novel aspects of natural and modified vinca alkaloids","volume":"2","author":"Duflos","year":"2002","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"2","key":"10.1016\/j.bas.2025.104292_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00277-002-0585-x","article-title":"German multicenter study group for adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results","volume":"82","author":"Dugas","year":"2003","journal-title":"Ann. Hematol."},{"issue":"18","key":"10.1016\/j.bas.2025.104292_bib18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198911023211816","article-title":"Treatment of inadvertent intrathecal injection of vincristine","volume":"321","author":"Dyke","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00043426-199811000-00018","article-title":"Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention","volume":"20","author":"Fernandez","year":"1998","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bas.2025.104292_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00262339","article-title":"Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors","volume":"6","author":"Focan","year":"1981","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.bas.2025.104292_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/1097-0142(19830901)52:5<799::AID-CNCR2820520508>3.0.CO;2-Z","article-title":"Intrathecal vincristine. Report of a fatal case despite CNS washout","volume":"52","author":"Gaidys","year":"1983","journal-title":"Cancer"},{"issue":"5\u20136","key":"10.1016\/j.bas.2025.104292_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/10428199709050886","article-title":"Vindesine in the treatment of leukaemia","volume":"26","author":"G\u00f6kbuget","year":"1997","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02897227","article-title":"Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rats","volume":"26","author":"Greig","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"10.1016\/j.bas.2025.104292_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/MPH.0b013e3181b83fba","article-title":"Intrathecal vincristine: 3 fatal cases and a review of the literature","volume":"31","author":"Hennipman","year":"2009","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"8 Pt 1","key":"10.1016\/j.bas.2025.104292_bib26","first-page":"2695","article-title":"Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells","volume":"40","author":"Howard","year":"1980","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bas.2025.104292_bib27","first-page":"31","article-title":"A phase II study of vindesine in patients with hematological malignancies","volume":"33","author":"Hulhoven","year":"1980","journal-title":"Biomedicine"},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0002-9343(88)90306-3","article-title":"Amelioration of vincristine neurotoxicity by glutamic acid","volume":"84","author":"Jackson","year":"1988","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3346\/jkms.1999.14.6.688","article-title":"Neural toxicity induced by accidental intrathecal vincristine administration","volume":"14","author":"Kwack","year":"1999","journal-title":"J Korean Med Sci."},{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/002580249603600314","article-title":"Accidental intraventricular vincristine administration: an avoidable iatrogenic death","volume":"36","author":"Lau","year":"1996","journal-title":"Med. Sci. Law"},{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00313734","article-title":"Accidental intrathecal vincristine administration. Report of a case","volume":"228","author":"Manelis","year":"1982","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/15563659809028947","article-title":"Fatality resulting from intraventricular vincristine administration","volume":"36","author":"Meggs","year":"1998","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"2","key":"10.1016\/j.bas.2025.104292_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2141.1997.3693183.x","article-title":"Potential salvage therapy for inadvertent intrathecal administration of vincristine","volume":"99","author":"Michelagnoli","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bas.2025.104292_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172472","article-title":"Alkaloids for cancer prevention and therapy: current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00257186","article-title":"Vindesine. A clinical trial with special reference to neurological side effects","volume":"2","author":"Obrist","year":"1979","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.bas.2025.104292_bib36","first-page":"S258","article-title":"Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature","volume":"94","author":"Pongudom","year":"2011","journal-title":"J. Med. Assoc. Thai."},{"issue":"3","key":"10.1016\/j.bas.2025.104292_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3171\/spi.2007.6.3.280","article-title":"Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report","volume":"6","author":"Qweider","year":"2007","journal-title":"J. Neurosurg. Spine"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clineuro.2010.08.008","article-title":"Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine?","volume":"113","author":"Reddy","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1476-5381.1988.tb11478.x","article-title":"Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine","volume":"93","author":"Rivera-Fillat","year":"1988","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00005072-196810000-00008","article-title":"Neuronal changes induced by intrathecal vincristine sulfate","volume":"27","author":"Schochet","year":"1968","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF00255905","article-title":"Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys","volume":"12","author":"Sethi","year":"1984","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mpo.2950050113","article-title":"Accidental intrathecal administration of vincristine","volume":"5","author":"Shepherd","year":"1978","journal-title":"Med. Pediatr. Oncol."},{"issue":"8","key":"10.1016\/j.bas.2025.104292_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.30.8.867","article-title":"Fatal myeloencephalopathy caused by intrathecal vincristine","volume":"30","author":"Slyter","year":"1980","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bas.2025.104292_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00257191","article-title":"Vindesine in the treatment of breast cancer","volume":"2","author":"Smith","year":"1979","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.bas.2025.104292_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00874146","article-title":"Is there a role for vindesine in the treatment of non-small cell lung cancer?","volume":"11","author":"S\u00f8rensen","year":"1993","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bas.2025.104292_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bas.2025.104292_bib47","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1556-4029.2006.00241.x","article-title":"Fatal accidental intrathecal injection of vindesine","volume":"51","author":"Tournel","year":"2006","journal-title":"J. Forensic Sci."},{"issue":"15","key":"10.1016\/j.bas.2025.104292_bib48","first-page":"4240","article-title":"Pharmacokinetics of vindesine in children: relationship with toxicity","volume":"49","author":"Vassal","year":"1989","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bas.2025.104292_bib49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.bas.2025.104292_bib50","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/1097-0142(19830601)51:11<2041::AID-CNCR2820511114>3.0.CO;2-G","article-title":"Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error","volume":"51","author":"Williams","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.bas.2025.104292_bib51","first-page":"2","year":"2007"},{"issue":"1","key":"10.1016\/j.bas.2025.104292_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mpo.2950240114","article-title":"Neurourologic consequences of accidental intrathecal vincristine: a case report","volume":"24","author":"Zaragoza","year":"1995","journal-title":"Med. Pediatr. Oncol."}],"container-title":["Brain and Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772529425001110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772529425001110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T16:48:07Z","timestamp":1772470087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772529425001110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":51,"alternative-id":["S2772529425001110"],"URL":"https:\/\/doi.org\/10.1016\/j.bas.2025.104292","relation":{},"ISSN":["2772-5294"],"issn-type":[{"value":"2772-5294","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inadvertent intrathecal application of vindesine and its neurological outcome: case report and systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Brain and Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bas.2025.104292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of EUROSPINE, the Spine Society of Europe, EANS, the European Association of Neurosurgical Societies.","name":"copyright","label":"Copyright"}],"article-number":"104292"}}